Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma.

被引：0
|
作者：
Gatwood, Justin
Dashputre, Ankur
Wallace, Alex
Gatwood, Katie S.
Farris, Karen B.
Mackler, Emily R.
Rizvi-Toner, Amna
Rajpurohit, Abhijeet
Farley, Joel
机构：
[1] Univ Tennessee, Coll Pharm, Nashville, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[3] Univ Tennessee, Hlth Sci Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[6] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[7] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[8] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18760
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18760
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma
    Gatwood, Justin
    Dashputre, Ankur
    Rajpurohit, Abhijeet
    Gatwood, Katie
    Mackler, Emily
    Wallace, Leah
    Farris, Karen
    Rizvi-Toner, Amna
    Farley, Joel
    JCO ONCOLOGY PRACTICE, 2022, 18 (09) : 671 - E1483
  • [2] Impact of adherence to pomalidomide on medication adherence in pre-existing chronic conditions in patients with multiple myeloma.
    Gatwood, Justin
    Dashputre, Ankur
    Gatwood, Katie S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Oral anticancer agent medication adherence by outpatients
    Kimura, Michio
    Usami, Eiseki
    Iwai, Mina
    Nakao, Toshiya
    Yoshimura, Tomoaki
    Mori, Hiromi
    Sugiyama, Tadashi
    Teramachi, Hitomi
    ONCOLOGY LETTERS, 2014, 8 (05) : 2318 - 2324
  • [4] Association of socioeconomic status with adherence to oral agents in patients with multiple myeloma.
    Rutter, Wilbur
    Prakash, Shivaani
    Cavers, William
    Avalos-Reyes, Elisea
    Johnson, Kjel Andrew
    Bernal-Mizrachi, Leon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Oral idarubicin as single agent therapy for patients with relapsed multiple myeloma.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Rodriguez, M
    Mateos, P
    Laufente, A
    Treleaven, J
    BLOOD, 1997, 90 (10) : 4144 - 4144
  • [6] Patterns and predictors of electronically measured oral anticancer medication (OAM) adherence among patients with multiple myeloma (MM)
    Sereika, Susan M.
    Dunbar-Jacob, Jacqueline
    Yeager, Katherine
    Rosenzweig, Margaret Q.
    Agha, Mounzer E.
    Muluneh, Benyam
    Sabik, Lindsay M.
    Copeland, Valire
    McGregor, Sarah
    Bender, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma.
    Diamond, T
    Levy, S
    Manoharan, A
    Smart, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T733 - T733
  • [8] Factors associated with non-adherence to lenalidomide in patients with multiple myeloma.
    Leng, Siyang
    Lentzsch, Suzanne
    Chen, Yizhen
    Accordino, Melissa Kate
    Wright, Jason Dennis
    Neugut, Alfred I.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Changes in neutrophil phenotype following the administration of CC-4047 (Actimid) to patients with multiple myeloma.
    Streetly, M
    Macey, MG
    McCarthy, DA
    Knight, R
    Fields, P
    Brown, KA
    Schey, SA
    BLOOD, 2003, 102 (11) : 687A - 687A
  • [10] Oral therapy adherence and satisfaction in patients with multiple myeloma
    Marine Solano
    Etienne Daguindau
    Cyril Faure
    Pierre Loriod
    Coline Pain
    Anne-Cécile Maes
    Pauline Marguet
    Marie Kroemer
    Anne Rumpler
    Jean Fontan
    Eric Deconinck
    Samuel Limat
    Anne-Laure Clairet
    Annals of Hematology, 2021, 100 : 1803 - 1813
12345